<!DOCTYPE html>
<html lang="en" dir="ltr">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Charles' Curriculum Vitae</title>
  <link rel="stylesheet" href="css/styles.css">
  <link rel="icon" href="favicon.ico">
</head>

<body>
  <table cellspacing="10" style="width:80%">
    <tr>
      <td><img src="images/DSC05331_crop.jpg" alt="charles chang profile picture" width="200"></td>
      <td>
        <h1>Charles A. Chang, PhD</h1>
          <p><em>
            Biotech Scientist<br>
            Islet Cell & BMT Specialist<br>
            San Francisco Bay Area, California</em>
          </p>
          <p>
            I am a biomedical scientist and cell therapy manufacturing consultant currently working in the SF Bay Area.
          </p>
          <p>
            My research experience has spanned from organic chemistry synthesis of vaccine adjuvants and antibody-drug conjugates,
            to chemical modification and reducing inflammation of transplanted living tissue,
             immune tolerance and treatment of autoimmune disease through bone marrow chimerism, and discovery of novel non-genotoxic bone marrow conditioning agents.
          </p>
          <p>
            Having spent nearly a decade working in and around hospitals, I am comfortable interacting with clinicians in high-pressure mission-critical environments. I have also worked directly with Organ Procurement Organizations (OPOs) from initial protocol authoring, to being on-call for screening offers, to organ retrieval or receipt.
          </p>
        <p>
          In addition to basic wet lab experience including cell sorting and high parameter (up to 18-color) flow cytometry, I have extensive hands-on experience in mouse models, porcine models, as well as non-human primate and human tissues, and the IACUC/IRB/USDA/USFWS regulations surrounding their usage. I am familiar with relevant Contract Research Organizations (CROs) and proficient in quickly establishing effective study protocols with relevant high-confidence methods.
        </p>
        <p>
          I have a strong innate go-getter attitude which contributes to my success and the success of the team. I am patient, perceptive, and a good listener, making me an effective colleague and mentor. Important values to me include: humble competence, innovative & efficient problem solving, and energizing inspiration.
        </p>
          <p>
            My professional goals are to use my strong technical skills and experience to advance curative treatments in the cell therapy and biologics spaces.
          </p>
        </td>
    </tr>
  </table>

  <hr>

  <h3>Work Experience</h3>
  <div class="table-responsive">
    <table class="table" cellspacing="1" border="1" style="width:80%">
      <thead>
          <th>Dates</th>
          <th>Work</th>
          <th>Description</th>
      </thead>
        <tr>
          <td>2023-present</td>
          <td>Principal Scientist at Inograft Biotherapeutics (Formerly 48 Bio)</td>
          <td>Introduced fundamental mouse models of bone marrow conditioning and transplant, and validated a novel "primatized" mouse model, to test novel molecules developed in-house. <br>Trained and transfered SOPs to junior scientists and research associates including animal handling, flow cytometry, and lentiviral transduction. <br>Acted as a cross-functional scientific and technical resource to aid in experimental design and execution. <br>Rapidly established a critical CRO relationship to translate murine proof-of-concept findings into NHP. <br>Successfully adapted previous human bone marrow isolation experience to NHP to enable critical studies with NHP bone marrow. <br>Routinely perform high-parameter flow cytometry and cell sorting on mouse, NHP, and human cells. <br>Have regular meetings with company leadership to discuss data and identify priority next steps.</td>
        </tr>
        <tr>
          <td>2022-2023</td>
          <td>Scientist->Senior Scientist at Jasper Therapeutics</td>
          <td>Aided in the initial setup of the lab space. <br>Introduced new disease and transplant models used to provide IND-enabling studies in the company's gene therapy and transplant pipelines. <br>Performed proof-of-concept studies in mice and designed NHP studies based on the results. <br>Helped the company quickly pivot from bone marrow conditioning and stem cell transplant to mast-cell diseases by developing key models in-house for proof-of-concept studies demonstrated by multiple poster presentations at important conferences within a year.</td>
        </tr>
        <tr>
          <td>2018-2023</td>
          <td>GMP Islet & Bone Marrow Manufacturing Consultant at Stanford Health Care</td>
          <td>Aided in the setup of space within the Cell Therapy Facility to manufacture human islets, bone marrow, and splenocytes. <br>Provided staff training to isolate bone marrow and pancreatic islets from deceased donors. <br>Established partnership with existing islet isolation center to enable the initial autologous islet cell transplants. <br>Personally recovered pancreas from Stanford OR and maintained chain-of-custody during transported to remote islet isolation center and returned with islet cell product for infusion. <a href="https://stanfordhealthcare.org/stanford-health-care-now/2023/physicians-perform-stanford-health-cares-first-autologous-islet-transplants-in-two-patients.html">Link</a></td> 
        </tr>
        <tr>
          <td>2018-2022</td>
          <td>Postdoctoral Fellow at Stanford School of Medicine</td>
          <td>Trained and assised PhD students and other postdocs with transplant and cell isolation studies in mice, rat, pig, non-human-primate, and human tissues. <br>Published a study demonstrating immunosuppression-free islet transplant tolerance. <br>Collaborated internally with grad students & other postdocs, and with external collaborators on multiple projects, resulting in multiple successful publications.</td>
        </tr>
        <tr>
          <td>2015-2018</td>
          <td>GMP Islet Cell Specialist at Baylor Medical Center</td>
          <td>Assisted with and eventually led the islet manufacturing team. <br>Manufactured human islets to GMP standards. Coordinated with surgical team for pancreas pickup and islet delivery and infusion. </td>
        </tr>
    </table>
  </div>

<hr>

<h3>Education</h3>
<div class="table-responsive">
  <table class="table" cellspacing="1" border="1" style="width:80%">
    <thead>
      <th>Dates</th>
      <th>Location</th>
    </thead>
    <tr>
      <td>2013-2018</td>
      <td>PhD in Biomedical Studies from Baylor University & Baylor Scott & White Research Institute.</td>
    </tr>
    <tr>
      <td>2009-2013</td>
      <td>B.S. in Biology and PhD in Biomedical Studies from Baylor University.</td>
    </tr>
  </table>
</div>

<hr>

<h3>Courses Taken</h3>
<div class="table-responsive">
  <table class="table" cellspacing="1" border="1" style="width:80%">
    <thead>
      <th>Dates</th>
      <th>Course</th>
    </thead>
    <tr>
      <td>Completed December 2022</td>
      <td><a href="https://www.udemy.com/course/an-entire-mba-in-1-courseaward-winning-business-school-prof/">An Entire MBA in 1 Course:Award Winning Business School Prof</a> by Chris Haroun</td>
    </tr>
    <tr>
      <td>September 2022-Present</td>
      <td><a href="https://www.udemy.com/course/100-days-of-code/">100 Days of Code: The Complete Python Pro Bootcamp</a> by Dr. Angela Yu</td>
    </tr>
  </table>
</div>

<hr>

  <h3>Publications, Patents, Presentations, & Posters</h3>
      <ul>
     
      <h3 style="text-align:center">2025</h3>

      <li>Hye-Sook Kwon, Song Eun Lee, Ajay Sharma, Minyoung Youn, <strong>Charles A. Chang</strong>, Andrew Wells, Andrea Romo, Allison Ji, Sara Ratia, Sambidhan Kattal, Revati Narkar, Karl, Meneses, Charl Kwan, Mang Yu, Wendy W Pang. Human KIT antibody briquilimab diminishes anaphylactic responses in mice expressing chimeric human-mouse KIT. 2025</li><br>
      <ul>
        <li>Under review at Allergy</li><br>
      </ul>
      
      <li>Preksha Bhagchandani, Stephan A. Ramos, Bianca Rodriguez, Xueying Gu, Shiva Pathak, Yuqi Zhou, Yujin Moon, Nadia Nourin, <strong>Charles A. Chang</strong>, Jessica Poyser, Brenda J. Velasco, Weichen Zhao, Hye-Sook Kwon, Richard Rodriguez, Diego Burgos, Mario A. Miranda, Everett Meyer, Judith A. Shizuru, Seung K. Kim. Curing autoimmune diabetes with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning. bioRxiv 2025.09.05.673576; doi: https://doi.org/10.1101/2025.09.05.673576. <a href="https://www.biorxiv.org/content/10.1101/2025.09.05.673576v1">Link</a></li><br>
      <ul>
        <li>Under review at JCI</li>
      </ul>
      
      <h3 style="text-align:center">2024</h3>
      <li><strong>Chang C</strong>, Sharma A, Wells A, Nerkar R, Meneses K, Kwon H, Pang W. Briquilimab, An Anti-CD117 Antibody, Prevents Passive Systemic Anaphylaxis In Mice Expressing Chimeric Human And Mouse CD117 Through Mast Cell Depletion. Journal of Allergy and Clinical Immunology (2024) 153(2) AB9. DOI: 10.1016/j.jaci.2023.11.050. <a href="https://www.jacionline.org/article/S0091-6749(23)01541-5/fulltext">Link</a></li><br>
      <ul>
        <li>Poster @ AAAAI Annual Scientific Meeting</li><br>
      </ul>
      <li><strong>Chang C</strong>, Sharma A, Ji A, Nerkar R, Martell K, Meneses K, Kwon H, Pang W. Amelioration Of Mrgprb2-Mediated Anaphylactoid Drug Reactions With Briquilimab, An Anti-CD117 Antibody, Through Mast Cell Depletion In Mice Expressing Chimeric Human And Mouse CD117. Journal of Allergy and Clinical Immunology (2024) 153(2) AB241. <a href="https://www.jacionline.org/article/S0091-6749(23)02266-2/fulltext">Link</a></li><br>
      <ul>
        <li>Poster @ AAAAI Annual Scientific Meeting</li><br>
      </ul>
      <li>Coykendall VMN, Qian MF, Tellez K, Bautista A, Bevacqua RJ, Gu X, Hang Y, Neukam M, Zhao W, <strong>Chang C</strong>, MacDonald PE, Kim SK. RFX6 Maintains Gene Expression and Function of Adult Human Islet α-Cells. Diabetes. 2024 Mar 1;73(3):448-460. doi: 10.2337/db23-0483, PMID: 38064570. <a href="https://www.nature.com/articles/s41467-024-46070-9">Link</a></li><br>
      <li>Liu S, Ezran C, Wang MFZ, Li Z, Awayan K; <strong>Tabula Microcebus Consortium</strong>; Long JZ, De Vlaminck I, Wang S, Epelbaum J, Kuo CS, Terrien J, Krasnow MA, Ferrell JE Jr. An organism-wide atlas of hormonal signaling based on the mouse lemur single-cell transcriptome. Nat Commun. 2024 Mar 11;15(1):2188. doi: 10.1038/s41467-024-46070-9. PMID: 38467625; PMCID: PMC10928088. <a href="https://diabetesjournals.org/diabetes/article/73/3/448/153966/RFX6-Maintains-Gene-Expression-and-Function-of">Link</a></li><br>
     
      <h3 style="text-align:center">2023</h3>
      <li><strong>Chang CA</strong>, Sharma A, Wells A, Nerkar R, Meneses K, Kwon H, Pang W. Briquilimab, an anti-CD117 antibody, prevents passive systemic anaphylaxis in mice expressing chimeric human/mouse CD117.  Annals of Allergy, Asthma & Immunology, Volume 131, Issue 5, S25. <a href="https://www.annallergy.org/article/S1081-1206(23)00695-6/fulltext">Link</a></li><br>
      <ul>
        <li>Poster @ ACAAI Annual Scientific Meeting</li><br>
      </ul>
      <ul>
        <li>Related Patent: <a href="https://data.uspto.gov/patent-file-wrapper/dialog/63659296">Compositions And Methods For Depletion Of Mast Cells.</a></li><br>
      </ul>
      <li>Qian MF, Bevacqua RJ, Coykendall VM, Liu X, Zhao W, <strong>Chang CA</strong>, Gu X, Dai XQ, MacDonald PE, Kim SK. JCI Insight 2023 Dec 22;8(24):e170884. doi: 10.1172/jci.insight.170884. PMID: 37943614.</li><br>
     
      <h3 style="text-align:center">2022</h3>
      <li><strong>Chang CA</strong>, Bhagchandani P, Poyser J, Velasco BJ, Zhao W, Kwon HS, Meyer E, Shizuru JA, Kim SK. Curative islet and hematopoietic cell transplantation in diabetic mice without toxic bone marrow conditioning. Cell Rep. 2022 Nov 8;41(6):111615. doi: 10.1016/j.celrep.2022.111615. PMID: 36351397.</li><br>
      <ul>
        <li>Preview: </strong><a href="https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01566-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124722015662%3Fshowall%3Dtrue"> Bone marrow chimerism breaks the barrier to pancreatic islet transplantation.</a></li><br>
      </ul>
      <li>Bhagchandani, P., <strong>Chang, C.A.</strong>, Zhao, W. et al. Islet cell replacement and transplantation immunology in a mouse strain with inducible diabetes. Sci Rep 12, 9033 (2022). https://doi.org/10.1038/s41598-022-13087-3</li><br>
      <li>
        <strong>Tabula Sapiens Consortium*</strong>, Jones RC, Karkanias J, Krasnow MA, Pisco AO, Quake SR, Salzman J, Yosef N, Bulthaup B, Brown P, Harper W, Hemenez M, Ponnusamy R, Salehi A, Sanagavarapu BA, Spallino E, Aaron KA, Concepcion W, Gardner JM, Kelly B, Neidlinger N, Wang Z, Crasta S, Kolluru S, Morri M, Pisco AO, Tan SY, Travaglini KJ, Xu C, Alcántara-Hernández M, Almanzar N, Antony J, Beyersdorf B, Burhan D, Calcuttawala K, Carter MM, Chan CKF, <strong>Chang CA</strong>, Chang S, Colville A, Crasta S, Culver RN, Cvijović I, D'Amato G, Ezran C, Galdos FX, Gillich A, Goodyer WR, Hang Y, Hayashi A, Houshdaran S, Huang X, Irwin JC, Jang S, Juanico JV, Kershner AM, Kim S, Kiss B, Kolluru S, Kong W, Kumar ME, Kuo AH, Leylek R, Li B, Loeb GB, Lu WJ, Mantri S, Markovic M, McAlpine PL, de Morree A, Morri M, Mrouj K, Mukherjee S, Muser T, Neuhöfer P, Nguyen TD, Perez K, Phansalkar R, Pisco AO, Puluca N, Qi Z, Rao P, Raquer-McKay H, Schaum N, Scott B, Seddighzadeh B, Segal J, Sen S, Sikandar S, Spencer SP, Steffes LC, Subramaniam VR, Swarup A, Swift M, Travaglini KJ, Van Treuren W, Trimm E, Veizades S, Vijayakumar S, Vo KC, Vorperian SK, Wang W, Weinstein HNW, Winkler J, Wu TTH, Xie J, Yung AR, Zhang Y, Detweiler AM, Mekonen H, Neff NF, Sit RV, Tan M, Yan J, Bean GR, Charu V, Forgó E, Martin BA, Ozawa MG, Silva O, Tan SY, Toland A, Vemuri VNP, Afik S, Awayan K, Botvinnik OB, Byrne A, Chen M, Dehghannasiri R, Detweiler AM, Gayoso A, Granados AA, Li Q, Mahmoudabadi G, McGeever A, de Morree A, Olivieri JE, Park M, Pisco AO, Ravikumar N, Salzman J, Stanley G, Swift M, Tan M, Tan W, Tarashansky AJ, Vanheusden R, Vorperian SK, Wang P, Wang S, Xing G, Xu C, Yosef N, Alcántara-Hernández M, Antony J, Chan CKF, Chang CA, Colville A, Crasta S, Culver R, Dethlefsen L, Ezran C, Gillich A, Hang Y, Ho PY, Irwin JC, Jang S, Kershner AM, Kong W, Kumar ME, Kuo AH, Leylek R, Liu S, Loeb GB, Lu WJ, Maltzman JS, Metzger RJ, de Morree A, Neuhöfer P, Perez K, Phansalkar R, Qi Z, Rao P, Raquer-McKay H, Sasagawa K, Scott B, Sinha R, Song H, Spencer SP, Swarup A, Swift M, Travaglini KJ, Trimm E, Veizades S, Vijayakumar S, Wang B, Wang W, Winkler J, Xie J, Yung AR, Artandi SE, Beachy PA, Clarke MF, Giudice LC, Huang FW, Huang KC, Idoyaga J, Kim SK, Krasnow M, Kuo CS, Nguyen P, Quake SR, Rando TA, Red-Horse K, Reiter J, Relman DA, Sonnenburg JL, Wang B, Wu A, Wu SM, Wyss-Coray T. The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans. Science. 2022 May 13;376(6594):eabl4896. doi: 10.1126/science.abl4896. Epub 2022 May 13. PMID: 35549404.
      </li><br>
      <li>Vorperian SK, Moufarrej MN; <strong>Tabula Sapiens Consortium*</strong>, Quake SR. Cell types of origin of the cell-free transcriptome. Nat Biotechnol. 2022 Jun;40(6):855-861. doi: 10.1038/s41587-021-01188-9. Epub 2022 Feb 7. Erratum in: Nat Biotechnol. 2022 Mar 28;: PMID: 35132263; PMCID: PMC9200634.</li>
     
      <h3 style="text-align:center">2021</h3>
      <li>Olivieri JE, Dehghannasiri R, Wang PL, Jang S, de Morree A, Tan SY, Ming J, Ruohao Wu A; <strong>Tabula Sapiens Consortium*</strong>, Quake SR, Krasnow MA, Salzman J. RNA splicing programs define tissue compartments and cell types at single-cell resolution. Elife. 2021 Sep 13;10:e70692. doi: 10.7554/eLife.70692. PMID: 34515025; PMCID: PMC8563012.</li><br>
      <li>Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, Jiang S, Demeter J, Bevacqua RJ, <strong>Chang CA</strong>, Whitener RL, Stalder AK, Zhu B, Chen H, Goltsev Y, Tzankov A, Nayak JV, Nolan GP, Matter MS, Andino R, Jackson PK. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021 Aug 3;33(8):1565-1576.e5. doi: 10.1016/j.cmet.2021.05.013. Epub 2021 May 18. PMID: 34081912; PMCID: PMC8130512.</li>
     
      <h3 style="text-align:center">2020</h3>
      <li>Tellez K, Hang Y, Gu X, <strong>Chang CA</strong>, Stein RW, Kim SK. In vivo studies of glucagon secretion by human islets transplanted in mice. Nat Metab. 2020 Jun;2(6):547-557. doi: 10.1038/s42255-020-0213-x. Epub 2020 Jun 8. PMID: 32694729; PMCID: PMC7739959.</li><br>
      <li>Kim S, Whitener RL, Peiris H, Gu X, <strong>Chang CA</strong>, Lam JY, Camunas-Soler J, Park I, Bevacqua RJ, Tellez K, Quake SR, Lakey JRT, Bottino R, Ross PJ, Kim SK. Molecular and genetic regulation of pig pancreatic islet cell development. Development. 2020 Mar 30;147(6):dev186213. doi: 10.1242/dev.186213. PMID: 32108026; PMCID: PMC7132804.</li>
     
      <h3 style="text-align:center">2018</h3>
      <li><strong>Chang CA</strong>, Murphy K, Kane RR, Lawrence MC, Naziruddin B. Early TLR4 Blockade Attenuates Sterile Inflammation-mediated Stress in Islets During Isolation and Promotes Successful Transplant Outcomes. Transplantation. 2018 Sep;102(9):1505-1513. doi: 10.1097/TP.0000000000002287. PMID: 29787520.</li><br>
      <li>Naziruddin B, Kanak MA, <strong>Chang CA</strong>, Takita M, Lawrence MC, Dennison AR, Onaca N, Levy MF. Improved outcomes of islet autotransplant after total pancreatectomy by combined blockade of IL-1β and TNFα. Am J Transplant. 2018 Sep;18(9):2322-2329. doi: 10.1111/ajt.14961. Epub 2018 Jun 25. PMID: 29862647.</li><br>
      <li>Saravanan PB, Kanak MA, <strong>Chang CA</strong>, Darden C, Yoshimatsu G, Lawrence MC, Naziruddin B. Islet damage during isolation as assessed by miRNAs and the correlation of miRNA levels with posttransplantation outcome in islet autotransplantation. Am J Transplant. 2018 Apr;18(4):982-989. doi: 10.1111/ajt.14615. Epub 2018 Jan 8. PMID: 29210193.</li>
      
      <h3 style="text-align:center">2017</h3>
      <li><strong>Chang CA</strong>, Akinbobuyi B, Quintana JM, Yoshimatsu G, Naziruddin B, Kane RR. Ex-vivo generation of drug-eluting islets improves transplant outcomes by inhibiting TLR4-Mediated NFkB upregulation. Biomaterials. 2018 Mar;159:13-24. doi: 10.1016/j.biomaterials.2017.12.020. Epub 2017 Dec 28. PMID: 29309990.</li><br>
      <ul>
        <li>Related Patent: <a href="https://ppubs.uspto.gov/api/patents/html/10814036?source=USPAT&requestToken=eyJzdWIiOiIyZmQ5Yzg1MC01M2QxLTQwMzctOWFkMC03YjIwZDEwYzI1YTciLCJ2ZXIiOiJhMWE2NDExMy0wOGMzLTRjMDAtYWVkYi0xNTQ2MjQxZjI1OTQiLCJleHAiOjB9">Drug-eluting live tissue for transplantation.</a></li><br>
      </ul>
      <li><strong>Chang CA</strong>, Lawrence MC, Naziruddin B. Current issues in allogeneic islet transplantation. Curr Opin Organ Transplant. 2017 Oct;22(5):437-443. doi: 10.1097/MOT.0000000000000448. PMID: 28692442.</li><br>
      <li>Yoshimatsu G, Kunnathodi F, Saravanan PB, Shahbazov R, <strong>Chang C</strong>, Darden CM, Zurawski S, Boyuk G, Kanak MA, Levy MF, Naziruddin B, Lawrence MC. Pancreatic β-Cell-Derived IP-10/CXCL10 Isletokine Mediates Early Loss of Graft Function in Islet Cell Transplantation. Diabetes. 2017 Nov;66(11):2857-2867. doi: 10.2337/db17-0578. Epub 2017 Aug 30. PMID: 28855240; PMCID: PMC5652609.</li>
     
      <h3 style="text-align:center">2016</h3>
      <li>Yoshimatsu G, Takita M, Kanak MA, Haque WZ, <strong>Chang C</strong>, Saravanan PB, Lawrence MC, Levy MF, Naziruddin B. MiR-375 and miR-200c as predictive biomarkers of islet isolation and transplantation in total pancreatectomy with islet autotransplantation. J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):585-94. doi: 10.1002/jhbp.377. Epub 2016 Aug 19. PMID: 27429015.</li>br
      <li>Akinbobuyi B, Wang L, Upchurch KC, Byrd MR, <strong>Chang CA</strong>, Quintana JM, Petersen RE, Seifert ZJ, Boquin JR, Oh S, Kane RR. Synthesis and immunostimulatory activity of substituted TLR7 agonists. Bioorg Med Chem Lett. 2016 Sep 1;26(17):4246-9. doi: 10.1016/j.bmcl.2016.07.049. Epub 2016 Jul 22. PMID: 27476423.</li><br>
      <li><strong>Chang CA</strong>, Haque WZ, Yoshimatsu G, Balajii PS, Lawrence MC, Naziruddin B. Monitoring of beta cell replacement outcomes. Panminerva Med. 2016 Mar;58(1):59-71. Epub 2016 Jan 13. PMID: 26763742.</li>
      
      <h3 style="text-align:center">2015</h3>
      <li>Akinbobuyi B, Byrd MR, <strong>Chang CA</strong>, Nguyen M, Seifert ZJ, Flamar AL, Zurawski G, Upchurch KC, Oh S, Dempsey SH, Enke TJ, Le J, Winstead HJ, Boquín JR, Kane RR. Facile syntheses of functionalized toll-like receptor 7 agonists. Tetrahedron Lett. 2015 Jan 8;56(2):458-460. doi: 10.1016/j.tetlet.2014.11.126. PMID: 25601818; PMCID: PMC4296738.</li><br>
    </ul>
    <hr>
    <a href="https://www.linkedin.com/in/charles-c-4a4124244/">View my LinkedIn</a><br>
</body>

</html>




























